tiprankstipranks
Advertisement
Advertisement
Contineum price target raised to $20 from $14 at Baird
PremiumThe FlyContineum price target raised to $20 from $14 at Baird
4M ago
Contineum Therapeutics Expands ATM Facility, Highlights Pipeline Progress
Premium
Company Announcements
Contineum Therapeutics Expands ATM Facility, Highlights Pipeline Progress
4M ago
Contineum reports Q4 EPS (49c), consensus (39c)
Premium
The Fly
Contineum reports Q4 EPS (49c), consensus (39c)
4M ago
Contineum Therapeutics Submits Phase 2 Trial for PIPE-791
PremiumCompany AnnouncementsContineum Therapeutics Submits Phase 2 Trial for PIPE-791
7M ago
Contineum offers to sell $75M in common stock
Premium
The Fly
Contineum offers to sell $75M in common stock
7M ago
Contineum price target lowered to $14 from $16 at Baird
Premium
The Fly
Contineum price target lowered to $14 from $16 at Baird
7M ago
Optimistic Buy Rating for Contineum Therapeutics Amid Promising PIPE-791 Developments
PremiumRatingsOptimistic Buy Rating for Contineum Therapeutics Amid Promising PIPE-791 Developments
8M ago
Contineum Therapeutics Reports Phase 2 Trial Results
Premium
Company Announcements
Contineum Therapeutics Reports Phase 2 Trial Results
8M ago
Contineum Therapeutics Inc trading resumes
Premium
The Fly
Contineum Therapeutics Inc trading resumes
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100